Infosys, Cera Sanitaryware, Tanla Platforms and More are Trading Below Buyback Price: What You Need to Know

Recently, many companies have executed their buyback and shares of those companies are trading below their buyback prices. Infosys recently announced one of the largest buybacks in the market, approving a tender offer worth ₹18,000 crore at a price of ₹1,800 per share. However, the stock is currently trading in the range of ₹1,635–₹1,656, remaining below the buyback price.

Infosys is not alone. Several companies with announced buybacks are currently trading well below their respective buyback prices. Notably, Cera Sanitaryware, which set its buyback price at ₹12,000 per share, continues to trade significantly below that level.

Cera Sanitaryware

Cera’s buyback marked the company’s first-ever repurchase programme. The firm last announced a bonus issue in 2010 in a 1:1 ratio. At present, the stock is trading nearly 57% below its buyback price.

Other Names on the List

Other stocks trading below their buyback prices include Technocraft, TTK Prestige, Welspun Living, Dhanuka Agritech, Tanla Platforms, KDDL, Nectar Lifesciences, AIA Engineering, GHCL, Aurobindo Pharma, Nureca, Fairchem Organics, Zydus Lifesciences, Bajaj Auto, Indus Towers and Infosys.

Tanla Platforms Buyback Details

Tanla Platforms’ board approved a ₹175 crore buyback in June, proposing to repurchase 20 lakh shares, around 1.5% of its equity, at ₹875 per share. The stock currently trades well below this level.

Also Read: January F&O Series Begins Today: Reduction in Lot Size and New Entrant, and More You Need to Know

What a Buyback Means for Investors

In a share buyback, a company repurchases its own shares, reducing the number of outstanding shares. Buybacks are often viewed as a tax-efficient way to return cash to shareholders and can enhance shareholder value over time.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.